Preliminary studies show conolidine may well inhibit specific ion channels, lessening neuronal excitability and restricting pain indicators. This system is particularly pertinent in neuropathic suffering, where abnormal signaling results in persistent discomfort. Moreover, conolidine seems to influence G protein-coupled receptor (GPCR) pathways int